相似文献
1
Rapid Optimization of the Metabolic Stability of a Human Immunodeficiency Virus Type-1 Capsid Inhibitor Using a Multistep Computational Workflow.
J Med Chem. 2021 Apr 8;64(7):3747-3766. doi: 10.1021/acs.jmedchem.0c01810. Epub 2021 Mar 22.
2
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
Eur J Med Chem. 2022 Jan 5;227:113903. doi: 10.1016/j.ejmech.2021.113903. Epub 2021 Oct 9.
3
Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
Eur J Med Chem. 2020 Aug 15;200:112427. doi: 10.1016/j.ejmech.2020.112427. Epub 2020 May 12.
4
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
Eur J Med Chem. 2021 Dec 15;226:113848. doi: 10.1016/j.ejmech.2021.113848. Epub 2021 Sep 16.
5
Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
J Virol. 2011 Jan;85(1):542-9. doi: 10.1128/JVI.01406-10. Epub 2010 Oct 20.
6
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
Eur J Med Chem. 2020 Mar 15;190:112085. doi: 10.1016/j.ejmech.2020.112085. Epub 2020 Jan 24.
7
Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74.
Viruses. 2021 Mar 15;13(3):479. doi: 10.3390/v13030479.
8
Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
Bioorg Med Chem Lett. 2016 Feb 1;26(3):824-828. doi: 10.1016/j.bmcl.2015.12.087. Epub 2015 Dec 25.
9
Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.
Sci Rep. 2017 Mar 2;7:43711. doi: 10.1038/srep43711.
10
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
J Med Chem. 2020 May 14;63(9):4790-4810. doi: 10.1021/acs.jmedchem.0c00015. Epub 2020 Apr 29.
引用本文的文献
1
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators.
J Med Chem. 2023 Dec 14;66(23):16303-16329. doi: 10.1021/acs.jmedchem.3c01647. Epub 2023 Dec 6.
2
Design, synthesis, and mechanistic study of 2-piperazineone-bearing peptidomimetics as novel HIV capsid modulators.
RSC Med Chem. 2023 Jun 2;14(7):1272-1295. doi: 10.1039/d3md00134b. eCollection 2023 Jul 20.
3
Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators.
Molecules. 2022 Dec 1;27(23):8415. doi: 10.3390/molecules27238415.
4
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators.
Molecules. 2022 Nov 7;27(21):7640. doi: 10.3390/molecules27217640.
5
Design, Synthesis and Structure-Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction.
Molecules. 2022 Sep 14;27(18):5995. doi: 10.3390/molecules27185995.
6
Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
J Med Virol. 2022 Dec;94(12):5975-5986. doi: 10.1002/jmv.28064. Epub 2022 Aug 18.
7
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
Eur J Med Chem. 2022 Jan 5;227:113903. doi: 10.1016/j.ejmech.2021.113903. Epub 2021 Oct 9.
8
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
Eur J Med Chem. 2021 Dec 15;226:113848. doi: 10.1016/j.ejmech.2021.113848. Epub 2021 Sep 16.
9
Synthesis, Enantiomeric Resolution and Biological Evaluation of HIV Capsid Inhibition Activity for Racemic, ()- and ()-PF74.
Molecules. 2021 Jun 26;26(13):3919. doi: 10.3390/molecules26133919.
本文引用的文献
1
Structure, Function, and Interactions of the HIV-1 Capsid Protein.
Life (Basel). 2021 Jan 29;11(2):100. doi: 10.3390/life11020100.
2
Clinical targeting of HIV capsid protein with a long-acting small molecule.
Nature. 2020 Aug;584(7822):614-618. doi: 10.1038/s41586-020-2443-1. Epub 2020 Jul 1.
3
Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
Eur J Med Chem. 2020 Aug 15;200:112427. doi: 10.1016/j.ejmech.2020.112427. Epub 2020 May 12.
4
Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
Viruses. 2020 Apr 16;12(4):452. doi: 10.3390/v12040452.
5
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
J Med Chem. 2020 May 14;63(9):4790-4810. doi: 10.1021/acs.jmedchem.0c00015. Epub 2020 Apr 29.
6
Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic Stability.
Molecules. 2020 Mar 21;25(6):1430. doi: 10.3390/molecules25061430.
7
Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors.
RSC Adv. 2019;9(50):28961-28986. doi: 10.1039/c9ra05869a. Epub 2019 Sep 16.
8
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
Eur J Med Chem. 2020 Mar 15;190:112085. doi: 10.1016/j.ejmech.2020.112085. Epub 2020 Jan 24.
9
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds.
Front Microbiol. 2019 Jun 20;10:1227. doi: 10.3389/fmicb.2019.01227. eCollection 2019.
10
Electrostatic Complementarity as a Fast and Effective Tool to Optimize Binding and Selectivity of Protein-Ligand Complexes.
J Med Chem. 2019 Mar 28;62(6):3036-3050. doi: 10.1021/acs.jmedchem.8b01925. Epub 2019 Mar 13.
Zotero 插件